Hypertension drug developer Retension (RTSN.US) IPO priced at $11-13 per share, aiming to raise $40 million.
Retension Pharmaceuticals (RTSN.US) announced the terms of its initial public offering (IPO) on Monday.
According to Golden Ten Data APP, US hypertension drug developer Retension Pharmaceuticals (RTSN.US) announced the terms of its initial public offering (IPO) on Monday. The company plans to issue 3.3 million shares at a price range of $11 to $13 per share, raising $40 million. Based on the midpoint of the offering price range, Retension's fully diluted market capitalization will reach $108 million.
Retension was founded in 2023 and is a clinical-stage biopharmaceutical company currently focused on developing a single product, RTN-001. This is a once-daily, oral PDE-5 inhibitor for the treatment of uncontrolled hypertension and resistant hypertension. First-generation PDE-5 inhibitors (such as Viagra) never achieved meaningful blood pressure-lowering effects. The company believes this is because such drugs have difficulty fully penetrating the central vascular system rich in smooth muscle, whereas RTN-001 has been redesigned to improve bioavailability and increase its distribution within these tissues.
This drug was initially developed by Surface Logix, then subsequently by Nano Terra, Kadmon, and Sanofi, until the current team reacquired its license in 2023, bringing data from 9 completed trials, including two phase 2 trials. In October 2025, the company started a phase 2b dose exploration trial involving 280 patients, with about 40% of patients enrolled so far, and preliminary data expected to be released in the first half of 2027.
Retension plans to list on Nasdaq under the stock code "RTSN", with Leerink Partners, Guggenheim Securities, and Oppenheimer & Co. acting as joint underwriters for the transaction. Pricing is expected during the week of October 5, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British builders grow more pessimistic: PMI rises to an eight-month high, but major projects are still being collectively shelved
UK builders became more pessimistic in September. The PMI rose to an eight-month high of 46.1 but remains in contraction territory; weak orders and Middle East conflicts are causing companies to delay project decisions.
European Central Bank board member warns: The Middle East energy shock has not yet affected wages, and the longer the conflict lasts, the greater the risks become.
European Central Bank member Rehn stated that the energy shock in the Middle East has not yet affected prices and wages, but the longer the conflict lasts, the greater the risk of transmission; the central bank has already raised interest rates twice, and rates may be raised again.
Silver price today: Silver broadly unchanged, according to FXStreet data
IREM names Kim Woo-jin, Sung Young-chul, Lee Hyung-do as director nominees in corrected filing
IREM issued a correction to its Sept. 4 board resolution calling an extraordinary shareholders’ meeting, updating the agenda to specify three director appointments. The meeting is scheduled for Oct. 21 at 9 a.m. at the company’s headquarters in Buan, North Jeolla Province. The revised slate includes the reappointment of CEO Woojin Kim as an inside director for a three-year term. The revised slate includes the appointment of Youngcheol Seong as an inside director for a three-year term. The revised slate includes the appointment of Hyungdo Lee as an independent director for a three-year term. The correction dated Oct. 6 was filed to reflect the finalized agenda items. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IREM Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006900738), on October 06, 2026, and is solely responsible for the information contained therein.
Crypto prices
More
